<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04372992</url>
  </required_header>
  <id_info>
    <org_study_id>ROPCR01</org_study_id>
    <nct_id>NCT04372992</nct_id>
  </id_info>
  <brief_title>The Stoma Closure Before or After Adjuvant Therapy Trial</brief_title>
  <acronym>STOMAD</acronym>
  <official_title>Multicenter Randomized Controlled Phase III Trial Comparing Ileostomy Closure Before or After Adjuvant Therapy in Patients Operated for Rectal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ospedale Umberto I di Torino</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rete Oncologica Piemonte, Valle d'Aosta</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ospedale Umberto I di Torino</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an open-label multicenter controlled trial, including 28 centers from the Rete
      Oncologica (Oncological Network) of Piemonte and Valle d'Aosta in Italy
      (http://www.reteoncologica.it). After a curative resection for rectal cancer and temporary
      ileostomy, 270 patients with indication to adjuvant chemotherapy will be randomized to early
      (before starting adjuvant treatment) or late (after adjuvant treatment completion) stoma
      closure. Primary end point will the compliance to adjuvant therapy. Secondary endpoint will
      include quality of life and bowel function evaluation, postoperative morbidity, chemotherapy
      toxicity, oncological outcomes and costs comparison.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diverting ileostomy is effective in reducing severity of anastomotic complications in rectal
      low anterior resections and it is therefore widely used especially after neoadjuvant
      chemoradiation treatment. In current clinical practice, in patients with indication to
      adjuvant chemotherapy, closure of ileostomy is usually performed after the end of the
      treatment. However, a prolonged presence of the ostomy can induce the onset of ostomy-related
      complications such as stoma prolapse, parastomal hernia, mechanical ileus, high flow
      dehydration and damage to renal function. The ostomy-related complications may require
      unplanned or prolonged hospitalization, thus increasing costs.

      Furthermore, the presence of the stoma may affect quality of life, causing alteration of the
      body image and imposing changes in the daily routine and lifestyle.

      Early closure of the ileostomy in patients without signs of postoperative fistula has
      therefore been proposed.

      Outcomes of early closure (within one month from surgery) of diverting ileostomy were
      demonstrated to be equal to those of late closure (more than 12 weeks from surgery) in 2
      randomized trials. Early closure may favor a better quality of life for patients, shortening
      the life-period with ileostomy, reduces health system economic expenditure and may represent
      the most desirable and convenient choice. It was also associated with better long term
      functional results in a randomized trial.

      In patients with indication to adjuvant therapy, however, timing to closure of the ostomy
      (before the start, during or at the end of treatment) is still a matter of debate in terms of
      compliance to systemic treatment, quality of life and overall costs.

      A recent multicenter retrospective study reported an increase in gastrointestinal toxicity in
      ostomy patients with a significant reduction in treatment compliance.

      On the other hand, early closure of the ostomy could unmask anterior resection syndrome
      (LARS) before chemotherapy, with potential negative impact on the tolerability of the
      treatment, or reveal postoperative complications thus delaying chemotherapy treatment.

      The trial will investigate which is the best strategy of dealing with temporary ileostomy in
      relation to adjuvant therapy.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2020</start_date>
  <completion_date type="Anticipated">June 2025</completion_date>
  <primary_completion_date type="Anticipated">June 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Multicenter controlled trial</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of participants with good compliance to adjuvant therapy</measure>
    <time_frame>Measured within 48 hours after the end of the last cycle of adjuvant therapy</time_frame>
    <description>Composite outcome measure including timeliness and percentage of planned dose received.
In each subject, treatment compliance is defined as good if both the following conditions are met:
adjuvant therapy starting date within 10 weeks of rectal resection;
total cumulative received dose (mg/m2) &gt;=70% of planned. The percentage of participants with good compliance in both arms will be compared.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of stoma-related complications</measure>
    <time_frame>All over the study duration (up to 12 months from randomization)</time_frame>
    <description>Adverse events related to the presence of stoma and postoperative complication after stoma closure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of chemotherapy side effects</measure>
    <time_frame>Immediately after the end of every single cycle (each cycle duration varies from 5 to 14 days according to the chosen scheme)</time_frame>
    <description>According to CTCAE classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life 1</measure>
    <time_frame>At baseline, at the end of cycle 3 (regardless of the cycle duration, that varies from 5 to 14 day according to local investigators choice) and at 12 months from randomization</time_frame>
    <description>Measured by EORTC C30</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life 2</measure>
    <time_frame>At baseline, at the end of cycle 3 (regardless of the cycle duration, that varies from 5 to 14 day according to local investigators choice) and at 12 months from randomization</time_frame>
    <description>Measured by EORTC CR29</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life 3</measure>
    <time_frame>At baseline, at the end of cycle 3 (regardless of the cycle duration, that varies from 5 to 14 day according to local investigators choice) and at 12 months from randomization</time_frame>
    <description>Measured by EQ-5D-3L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bowel function</measure>
    <time_frame>At 12 months from rectal resection</time_frame>
    <description>Measured by LARS (Low Anterior Resection Syndrome) score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>Ut to 3 years from inclusion of the last patient</time_frame>
    <description>From randomization date to death from any cause or date of last contact</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Progression free survival</measure>
    <time_frame>Ut to 3 years from inclusion of the last patient</time_frame>
    <description>From randomization date to progression diagnosis or date of last contact</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Costs analysis</measure>
    <time_frame>At 12 months from randomization</time_frame>
    <description>Mean cumulative costs in euro of the postoperative phase including outpatient visits, hospital stay for stoma closure, hospital re-entry and expenditures for stoma care appliances based on life-days with the stoma. Excluded are costs related to adjuvant treatment.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">270</enrollment>
  <condition>Ileostomy</condition>
  <condition>Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>Early stoma closure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ileostomy closure between 30 and 40 day after rectal resection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delayed stoma closure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ileostomy closure 15 days from the end of adjuvant therapy (up to 60 days)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Timing of stoma closure</intervention_name>
    <description>Defining the best timing of stoma closure in relation to adjuvant therapy compliance</description>
    <arm_group_label>Delayed stoma closure</arm_group_label>
    <arm_group_label>Early stoma closure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient treated with a curative resection for rectal cancer

          -  Presence of a temporary ileostomy

          -  Indication to adjuvant treatment

          -  Absence of anastomotic dehiscence (as proved by enema and/or endoscopy)

          -  Able to give written informed consent

        Exclusion Criteria:

          -  ASA &gt;3

          -  ECOG Performance Status &gt;=2

          -  UICC stage IV
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paolo Massucco, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>OA Ordine Mauriziano - Torino, Italy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paolo Massucco, MD</last_name>
    <phone>+393357110793</phone>
    <email>pmassucco@mauriziano.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ospedale Mons. Galliano - Chirurgia Generale (Dott. Serventi)</name>
      <address>
        <city>Acqui Terme</city>
        <state>AL</state>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Alberto Serventi, MD</last_name>
      <email>aserventi@aslal.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale SS. Antonio e Biagio - Chirurgia Generale (Dott. Priora)</name>
      <address>
        <city>Alessandria</city>
        <state>AL</state>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Igor Monsellato, MD</last_name>
      <email>igor.monsellato@ospedale.al.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Spirito - Chirurgia Generale (Dott. Amisano)</name>
      <address>
        <city>Casale Monferrato</city>
        <state>AL</state>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Francesca Cravero, MD</last_name>
      <email>fcravero@aslal.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Giacomo - Chirurgia Generale (Dott. Di Somma)</name>
      <address>
        <city>Novi Ligure</city>
        <state>AL</state>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Eliana Giaminardi, MD</last_name>
      <email>egiaminardi@aslal.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Cardinal Massaia - Chirurgia Generale (Dott. Sorisio)</name>
      <address>
        <city>Asti</city>
        <state>AT</state>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Luca Mazza, MD</last_name>
      <email>lmazza@asl.at.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale degli Infermi - Chirurgia Generale (Dott. Polastri)</name>
      <address>
        <city>Biella</city>
        <state>BI</state>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Roberto Perinotti, MD</last_name>
      <email>roberto.perinotti@aslbi.piemonte.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Croce e Carle - Chirurgia Generale (Dott. Borghi)</name>
      <address>
        <city>Cuneo</city>
        <state>CN</state>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Carmen Giuffrida, MD</last_name>
      <email>mc_giuffrida@email.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Regina Montis Regalis - Chirurgia Generale (Dott. Gattolin)</name>
      <address>
        <city>Mondovì</city>
        <state>CN</state>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Roberto Rimonda, MD</last_name>
      <email>roberto.rimonda@aslcn1.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale SS. Annunziata - Chirurgia Generale (Dott. Bertolino)</name>
      <address>
        <city>Savigliano</city>
        <state>CN</state>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Marco Brunetti, MD</last_name>
      <email>marco.brunetti@aslcn1.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>IRCCS - Chirurgia Colorettale (Dott. Ribero)</name>
      <address>
        <city>Candiolo</city>
        <state>TO</state>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Alfredo Mellano, MD</last_name>
      <email>alfredo.mellano@ircc.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale di Ciriè - Chirurgia Generale (Dott. Personettaz)</name>
      <address>
        <city>Ciriè</city>
        <state>TO</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile - Chirurgia Generale (Dott. Rosato)</name>
      <address>
        <city>Ivrea</city>
        <state>TO</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Croce - Chirurgia Generale (Dott. Cumbo)</name>
      <address>
        <city>Moncalieri</city>
        <state>TO</state>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Francesco Potente, MD</last_name>
      <email>potente.francesco@aslto5.piemonte.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Luigi - Chirurgia Universitaria (Prof. Degiuli)</name>
      <address>
        <city>Orbassano</city>
        <state>TO</state>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Rossella Reddavid, MD</last_name>
      <email>rossella.reddavid@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Agnelli - Chirurgia Generale (Dott. Muratore)</name>
      <address>
        <city>Pinerolo</city>
        <state>TO</state>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Marcello Calabrò, MD</last_name>
      <email>mcalabro@aslto3.piemonte.it</email>
    </contact>
    <contact_backup>
      <last_name>Nicoletta Pipitone, MD</last_name>
      <email>npipitone@aslto3.piemonte.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ospedale degli Infermi - Chirurgia Generale (Dott. Garino)</name>
      <address>
        <city>Rivoli</city>
        <state>TO</state>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Simone Birolo, MD</last_name>
      <email>sbirolo@aslto3.piemonte.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Cottolengo - Chirurgia Generale (Dott. Bima)</name>
      <address>
        <city>Torino</city>
        <state>TO</state>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Enrico Gabin, MD</last_name>
      <email>enrico.gibin.md@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Humanitas Gradenigo - Chirurgia Generale (Dott. Leli)</name>
      <address>
        <city>Torino</city>
        <state>TO</state>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Maria Paola Bellomo, MD</last_name>
      <email>mariapaola.bellomo@gradenigo.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Biagio - Chirurgia Generale (Dott. Zonta)</name>
      <address>
        <city>Domodossola</city>
        <state>VB</state>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Francesco Battafarano, MD</last_name>
      <email>francesco.battafarano@aslvco.it</email>
    </contact>
    <contact_backup>
      <last_name>Renza Trapani, MD</last_name>
      <email>renza.trapani@aslvco.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Andrea - Chirurgia Generale (Dott. Testa)</name>
      <address>
        <city>Vercelli</city>
        <state>VC</state>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Clemente De Rosa, MD</last_name>
      <email>clemente.derosa@aslvc.piemonte.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Lazzaro - Chirurgia Generale (Dott. Calgaro)</name>
      <address>
        <city>Alba</city>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Vincenzo Adamo, MD</last_name>
      <email>vadamo@aslcn2.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Parini - Chirurgia Generale (Dott. Millo)</name>
      <address>
        <city>Aosta</city>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Elisa Ponte, MD</last_name>
      <email>ely.ponte@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Maggiore della Carità - Chirurgia Generale (Dott. Romito)</name>
      <address>
        <city>Novara</city>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Fabio Colli, MD</last_name>
      <email>fabio.colli@maggioreosp.novara.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Maggiore della Carità - Chirurgia Universitaria (Prof. Gentilli)</name>
      <address>
        <city>Novara</city>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Paolo Bellora, MD</last_name>
      <email>paolo.bellora@maggioreosp.novara.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Martini - Chirurgia Generale (Dott. Saracco)</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Francesco Tomaselli, MD</last_name>
      <email>francesco.tomaselli@aslcittaditorino.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Mauriziano - Chirurgia Generale (Dott. Ferrero)</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Paolo Massucco, MD</last_name>
      <email>pmassucco@mauriziano.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Molinette - Chirurgia Generale (Dott. De Paolis)</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Mauro Santarelli, MD</last_name>
      <email>santamauro69@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Molinette - Chirurgia Universitaria (Prof. Morino)</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Massimiliano Mistrangelo, MD</last_name>
      <email>mistrangelo@katamail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Montedori A, Cirocchi R, Farinella E, Sciannameo F, Abraha I. Covering ileo- or colostomy in anterior resection for rectal carcinoma. Cochrane Database Syst Rev. 2010 May 12;(5):CD006878. doi: 10.1002/14651858.CD006878.pub2. Review.</citation>
    <PMID>20464746</PMID>
  </reference>
  <reference>
    <citation>Malik T, Lee MJ, Harikrishnan AB. The incidence of stoma related morbidity - a systematic review of randomised controlled trials. Ann R Coll Surg Engl. 2018 Sep;100(7):501-508. doi: 10.1308/rcsann.2018.0126. Epub 2018 Aug 16. Review.</citation>
    <PMID>30112948</PMID>
  </reference>
  <reference>
    <citation>Brown H, Randle J. Living with a stoma: a review of the literature. J Clin Nurs. 2005 Jan;14(1):74-81. Review.</citation>
    <PMID>15656851</PMID>
  </reference>
  <reference>
    <citation>Herrle F, Sandra-Petrescu F, Weiss C, Post S, Runkel N, Kienle P. Quality of Life and Timing of Stoma Closure in Patients With Rectal Cancer Undergoing Low Anterior Resection With Diverting Stoma: A Multicenter Longitudinal Observational Study. Dis Colon Rectum. 2016 Apr;59(4):281-90. doi: 10.1097/DCR.0000000000000545.</citation>
    <PMID>26953986</PMID>
  </reference>
  <reference>
    <citation>Alves A, Panis Y, Lelong B, Dousset B, Benoist S, Vicaut E. Randomized clinical trial of early versus delayed temporary stoma closure after proctectomy. Br J Surg. 2008 Jun;95(6):693-8. doi: 10.1002/bjs.6212.</citation>
    <PMID>18446781</PMID>
  </reference>
  <reference>
    <citation>Danielsen AK, Park J, Jansen JE, Bock D, Skullman S, Wedin A, Marinez AC, Haglind E, Angenete E, Rosenberg J. Early Closure of a Temporary Ileostomy in Patients With Rectal Cancer: A Multicenter Randomized Controlled Trial. Ann Surg. 2017 Feb;265(2):284-290. doi: 10.1097/SLA.0000000000001829.</citation>
    <PMID>27322187</PMID>
  </reference>
  <reference>
    <citation>Park J, Angenete E, Bock D, Correa-Marinez A, Danielsen AK, Gehrman J, Haglind E, Jansen JE, Skullman S, Wedin A, Rosenberg J. Cost analysis in a randomized trial of early closure of a temporary ileostomy after rectal resection for cancer (EASY trial). Surg Endosc. 2020 Jan;34(1):69-76. doi: 10.1007/s00464-019-06732-y. Epub 2019 Mar 25.</citation>
    <PMID>30911920</PMID>
  </reference>
  <reference>
    <citation>Keane C, Park J, Öberg S, Wedin A, Bock D, O'Grady G, Bissett I, Rosenberg J, Angenete E. Functional outcomes from a randomized trial of early closure of temporary ileostomy after rectal excision for cancer. Br J Surg. 2019 Apr;106(5):645-652. doi: 10.1002/bjs.11092. Epub 2019 Feb 1.</citation>
    <PMID>30706439</PMID>
  </reference>
  <reference>
    <citation>Tulchinsky H, Shacham-Shmueli E, Klausner JM, Inbar M, Geva R. Should a loop ileostomy closure in rectal cancer patients be done during or after adjuvant chemotherapy? J Surg Oncol. 2014 Mar;109(3):266-9. doi: 10.1002/jso.23493. Epub 2013 Nov 19.</citation>
    <PMID>24249401</PMID>
  </reference>
  <reference>
    <citation>Robertson JP, Wells CI, Vather R, Bissett IP. Effect of Diversion Ileostomy on the Occurrence and Consequences of Chemotherapy-Induced Diarrhea. Dis Colon Rectum. 2016 Mar;59(3):194-200. doi: 10.1097/DCR.0000000000000531.</citation>
    <PMID>26855393</PMID>
  </reference>
  <reference>
    <citation>Siassi M, Hohenberger W, Lösel F, Weiss M. Quality of life and patient's expectations after closure of a temporary stoma. Int J Colorectal Dis. 2008 Dec;23(12):1207-12. doi: 10.1007/s00384-008-0549-2. Epub 2008 Aug 7.</citation>
    <PMID>18685854</PMID>
  </reference>
  <reference>
    <citation>Chow A, Tilney HS, Paraskeva P, Jeyarajah S, Zacharakis E, Purkayastha S. The morbidity surrounding reversal of defunctioning ileostomies: a systematic review of 48 studies including 6,107 cases. Int J Colorectal Dis. 2009 Jun;24(6):711-23. doi: 10.1007/s00384-009-0660-z. Epub 2009 Feb 17. Review.</citation>
    <PMID>19221766</PMID>
  </reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 20, 2020</study_first_submitted>
  <study_first_submitted_qc>April 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2020</study_first_posted>
  <last_update_submitted>April 29, 2020</last_update_submitted>
  <last_update_submitted_qc>April 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ospedale Umberto I di Torino</investigator_affiliation>
    <investigator_full_name>Paolo Massucco</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Chemotherapy, Adjuvant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

